France launches public consultation on legalising cannabis
France is Europe’s biggest cannabis consumer, despite having some of the continent’s toughest laws against the drug.
France is Europe’s biggest cannabis consumer, despite having some of the continent’s toughest laws against the drug.
Medical cannabis, or cannabinoid-based products, continues to grow in popularity globally, driving the evolution of regulatory access frameworks; cancer patients and caregivers often rely on guidance from their physicians regarding cannabinoid-based treatments.
Prisons should trial free cannabis schemes for drug-dependent inmates to ascertain whether it could reduce overdose deaths, bring down violence and help people overcome opioid addiction, a police and crime commissioner has said.
The reforms would allow the legal cultivation of marijuana on Mexican soil after decades of violence between drug cartels and authorities.
Recently, many countries have enacted new cannabis policies, including decriminalization of cannabis possession as well as legalization of medical and recreational cannabis. In this context, patients and their physicians have had an increasing number of conversations about the risks and benefits of cannabis.
In November, pot stocks soared on both a Joe Biden presidential win and the legalization of recreational marijuana in four more states (Arizona, Montana, New Jersey, and South Dakota).